Peptic ulcer bleeding is one of the most common emergency situations in medicine. Combined pharmacological and endoscopic therapy together with emerging interventional radiological procedures are successfully treating peptic ulcer disease, reserving surgical procedures for only a small portion of patients unresponsive to ‘conventional’ therapy. Technological advancement has seen a great improvement in the field of endoscopic treatment in the form of various methods of hemostasis. However, pharmacological therapy with proton pump inhibitors still plays the central role in the peptic ulcer bleeding treatment algorithm.

Aabakken L: Current endoscopic and pharmacological therapy of peptic ulcer bleeding. Best Pract Res Clin Gastroenterol 2008;22:243–259.
Palmer K: Acute upper gastrointestinal haemorrhage. Br Med Bull 2007;83:307–324.
Cappell MS: Therapeutic endoscopy for acute upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol 2010;7:214–229.
Van Leerdam ME: Epidemiology of acute upper gastrointestinal bleeding. Best Practice Res Clin Gastroenterol 2008;22:209–224.
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach patients with gastritis and peptic ulceration. Lancet 1984;1:1311–1315.
Ramsoekh D, van Leerdam ME, Rauws EA, Tytgat GN: Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol 2005;3:859–864.
Richardson CT: Pathogenetic factors in peptic ulcer disease. Am J Med 1985;79:1–7.
Laine L, Takeuchi K, Tarnawski A: Gastric mucosal defence and cytoprotection: bench to bedside. Gastroenterology 2008;135:41–60.
Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T: Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol 2005;56(suppl 5):33–55.
Calam J, Baron JH: ABC of the upper gastrointestinal tract: pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ 2001;323:980–982.
Shajan P, Wilcox CM: Endoscopic therapy for peptic ulcer bleeding. Intervent Ther Gastrointest Endosc 2010;27:37–54.
Gralnek IM, Barkun AN, Bardou M: Management of acute bleeding from a peptic ulcer. N Engl J Med 2008;359:928–937.
Lau JY, Chung SC, Leung JW, Lo KK, Yung MY, Li AK: The evolution of stigmata of hemorrhage in bleeding peptic ulcer: a sequential endoscopic study. Endoscopy 1998;30:513–518.
Klebl FH, Schölmerich J: Future expectations in the prophylaxis of intestinal bleeding. Best Pract Res Clin Gastroenterol 2008;22:373–387.
Loffroy R, Rao P, Ota S, De Lin M, Kwak BK, Geschwind JF: Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol 2010;33:1088–1100.
Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, Chan FK, Ng EK, You JH, Lee CW, Chan AC, Chung SC: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310–316.
Sung JJ, Barkun AN, Kuipers EJ, Mössner J, Jensen DM, Stuart R, Lau JY, Ahlbom H, Kilhamn J, Lind T; Peptic ulcer bleed study group: intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding. Ann Intern Med 2009;150:455–464.
Brunner G, Luna P, Hartmann M, Wurst W: Optimizing the intragastric pH as a supportive therapy in upper gastrointestinal bleeding. Yale J Biol Med 1996;69:225–231.
Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE: Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol 2005;20:11–25.
Tsoi KK, Lau JY, Sung JJ: Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper gastrointestinal bleeding. Gastrointest Endosc 2008;67:1056–1063.
Leontiadis GI, Sreedharan A, Dorward S, Barton P, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D: Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007;11:iii–iv, 1–164.
Laine L, Shah A, Bemanian S: Intragastric pH with oral vs. intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology 2008;134:1836–1841.
García Sánchez MV, López Vallejos P, González Galilea A, Gálvez Calderón C, Naranjo Rodríguez A, Sánchez-Trembleque Zarandona MD, Hervás Molina A, de Dios Vega JF: Factors associated with failure of endoscopic therapy in gastric ulcer bleeding. Gastroenterol Hepatol 2003;26:227–233.
Peter DJ, Dougherty JM: Evaluation of the patient with gastrointestinal bleeding: an evidence-based approach. Emerg Med Clin North Am 1999;17:239–261.
Millat B, Hay JM, Valleur P, Fingerhut A, Fagniez PL: Emergency surgical treatment for bleeding duodenal ulcer: oversewing plus vagotomy versus gastric resection, a controlled randomized trial. French Associations for Surgical Research. World J Surg 1993;17:568–574.
Barkun AN, Bardou M, Marshall JK; Nonvariceal Upper Gastrointestinal Bleeding Consensus Conference Group: Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003;139:843–857.
Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P; International Consensus Upper Gastrointestinal Bleeding Conference Group: International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010;152:101–113.
Hsu PI, Lo GH, Lo CC, Lin CK, Chan HH, Wu CJ, Shie CB, Tsai PM, Wu DC, Wang WM, Lai KH: Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 2004;10:3666–3669.
Barkun AN, Fallone CA, Chiba N, Fishman M, Flook N, Martin J, Rostom A, Taylor A; Nonvariceal Upper Gastrointestinal Bleeding Consensus Conference Group: A Canadian clinical practice algorithm for the management of patients with nonvariceal upper gastrointestinal bleeding. Can J Gastroenterol 2004;18:605–609.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.